RUNX2 is closely related to the proliferation, invasion, and bone metastasis in multiple cancer types, such as osteosarcoma, breast cancer (BC), prostate cancer, gastric cancer, colorectal cancer, and lung cancer [7–10, 18]. Here, RUNX2 is linked to lung carcinoma.